Celldex Therapeutics Raises $345 Million in Public Offering of Common Stock

Lowenstein Sandler LLP has advised Celldex Therapeutics, Inc., and Wilmer Cutler Pickering Hale and Dorr has represented the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) has announced…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here